Mounjaro (tirzepatide) is a prescription brand-name injectable medicine approved to improve blood sugar levels in adults and children aged 10 and older with type 2 diabetes, alongside diet and exercise. It is also known to cause significant weight loss, though the identical active ingredient is marketed as Zepbound for chronic weight management.Mounjaro, tirzepatide
- Acts as a dual GIP/GLP-1 receptor agonist, mimicking two natural gut hormones.
- Stimulates insulin secretion and suppresses glucagon release only when blood sugar is high.
- Slows stomach digestion down, which reduces appetite and helps you feel full longer.
- Delivered as a once-weekly subcutaneous injection (under the skin) in the abdomen, thigh, or upper arm.
- Available in single-dose pens and vials ranging from 2.5 mg up to 15 mg per 0.5 mL.
- Can interact with oral birth control pills, potentially making them less effective during initial weeks or dose increases
- Common: Nausea, diarrhea, vomiting, decreased appetite, constipation, indigestion, and stomach pain.
- Serious: Risk of thyroid C-cell tumors (seen in animal studies), pancreatitis, gallbladder problems, kidney injury, and severe allergic reactions.
- Contraindications: Do not use if you have a personal or family history of medullary





Reviews
There are no reviews yet.